Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Net Income (2018 - 2025)

Historic Net Income for Bio (TELA) over the last 8 years, with Q3 2025 value amounting to -$8.6 million.

  • Bio's Net Income rose 1705.55% to -$8.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$39.1 million, marking a year-over-year increase of 736.94%. This contributed to the annual value of -$37.8 million for FY2024, which is 1890.75% up from last year.
  • As of Q3 2025, Bio's Net Income stood at -$8.6 million, which was up 1705.55% from -$9.9 million recorded in Q2 2025.
  • Bio's 5-year Net Income high stood at -$5.7 million for Q1 2024, and its period low was -$13.6 million during Q4 2023.
  • In the last 5 years, Bio's Net Income had a median value of -$10.5 million in 2022 and averaged -$10.2 million.
  • As far as peak fluctuations go, Bio's Net Income surged by 5471.2% in 2024, and later crashed by 9897.54% in 2025.
  • Quarter analysis of 5 years shows Bio's Net Income stood at -$8.6 million in 2021, then decreased by 23.75% to -$10.6 million in 2022, then decreased by 28.36% to -$13.6 million in 2023, then skyrocketed by 31.35% to -$9.4 million in 2024, then increased by 8.01% to -$8.6 million in 2025.
  • Its Net Income was -$8.6 million in Q3 2025, compared to -$9.9 million in Q2 2025 and -$11.3 million in Q1 2025.